GENEVA, July 8 -- JIANGSU ALPHAMAB BIOPHARMACEUTICALS CO., LTD. (No. 175 Fangzhou Road, SIPSuzhou, Jiangsu 215000), 江苏康宁杰瑞生物制药有限公司 (中国江苏省苏州市苏州工业园区方洲路175号) filed a patent application (PCT/CN2024/142837) for "MULTI-SPECIFIC ANTIBODY TARGETING HER3 AND TROP2 AND CONJUGATE THEREOF" on Dec 26, 2024. With publication no. WO/2025/140438, the details related to the patent application was published on Jul 03, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is ...